Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human Evaluation of STARgraft AV for Hemodialysis Access in Comparison to ePTFE Vascular Grafts

NCT03916731 is registered in ClinicalTrials.gov with Healionics Corporation as lead sponsor.

NCT NCT03916731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03916731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human Evaluation of STARgraft AV for Hemodialysis Access in Comparison to ePTFE Vascular Grafts
Lead sponsor
Healionics Corporation
Phase
Not applicable
Overall status
Completed
Start date
April 2, 2019
Completion date
May 11, 2021
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease